West Pharmaceutical Services Inc (WST) — Cash Flow Reinvestment Rate
West Pharmaceutical Services Inc (WST) has a Cash Flow Reinvestment Rate of 0.47x as of March 2026, reinvesting $42.70 Million (capex $42.70 Million ) from operating cash flow of $89.90 Million. Check WST cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
West Pharmaceutical Services Inc Cash Flow Reinvestment Rate (1989–2025)
Historical reinvestment intensity for West Pharmaceutical Services Inc across 37 annual periods. Explore WST long-term investments to assets to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for West Pharmaceutical Services Inc (1989–2025)
Year-by-year capital reinvestment analysis for West Pharmaceutical Services Inc. For live market cap and broader valuation context, see WST stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.38x | $285.90 Million | $754.80 Million | $285.90 Million | ▼ -67.2% |
| 2024 | 1.16x | $755.70 Million | $653.40 Million | $377.00 Million | ▲ +25.3% |
| 2023 | 0.92x | $716.70 Million | $776.50 Million | $362.00 Million | ▲ +16.7% |
| 2022 | 0.79x | $572.80 Million | $724.00 Million | $284.60 Million | ▼ -8.8% |
| 2021 | 0.87x | $506.50 Million | $584.00 Million | $253.40 Million | ▲ +15.8% |
| 2020 | 0.75x | $353.90 Million | $472.50 Million | $174.40 Million | ▲ +30.0% |
| 2019 | 0.58x | $211.50 Million | $367.20 Million | $126.40 Million | ▼ -19.1% |
| 2018 | 0.71x | $205.50 Million | $288.60 Million | $104.70 Million | ▼ -29.1% |
| 2017 | 1.00x | $264.40 Million | $263.30 Million | $130.80 Million | ▲ +23.4% |
| 2016 | 0.81x | $178.60 Million | $219.40 Million | $170.20 Million | ▲ +29.9% |
| 2015 | 0.63x | $133.10 Million | $212.40 Million | $131.60 Million | ▼ -3.8% |
| 2014 | 0.65x | $119.10 Million | $182.90 Million | $112.10 Million | ▼ -10.7% |
| 2013 | 0.73x | $160.70 Million | $220.50 Million | $155.80 Million | ▼ -6.7% |
| 2012 | 0.78x | $146.40 Million | $187.40 Million | $132.00 Million | ▼ -16.6% |
| 2011 | 0.94x | $122.40 Million | $130.70 Million | $96.80 Million | ▲ +71.5% |
| 2010 | 0.55x | $75.50 Million | $138.30 Million | $73.80 Million | ▼ -30.3% |
| 2009 | 0.78x | $107.80 Million | $137.70 Million | $107.80 Million | ▼ -24.0% |
| 2008 | 1.03x | $139.10 Million | $135.00 Million | $139.10 Million | ▲ +2.9% |
| 2007 | 1.00x | $129.40 Million | $129.20 Million | $129.40 Million | ▲ +59.5% |
| 2006 | 0.63x | $90.30 Million | $143.80 Million | $90.30 Million | ▼ -0.6% |
| 2005 | 0.63x | $54.10 Million | $85.60 Million | $54.10 Million | ▼ -24.1% |
| 2004 | 0.83x | $57.40 Million | $68.90 Million | $57.40 Million | ▼ -5.2% |
| 2003 | 0.88x | $60.80 Million | $69.20 Million | $60.80 Million | ▲ +25.6% |
| 2002 | 0.70x | $37.70 Million | $53.90 Million | $37.70 Million | ▼ -48.1% |
| 2001 | 1.35x | $44.10 Million | $32.70 Million | $44.10 Million | ▲ +14.4% |
| 2000 | 1.18x | $57.30 Million | $48.60 Million | $57.30 Million | ▲ +29.1% |
| 1999 | 0.91x | $63.40 Million | $69.40 Million | $63.40 Million | ▼ -15.4% |
| 1998 | 1.08x | $76.70 Million | $71.00 Million | $76.70 Million | ▲ +112.6% |
| 1997 | 0.51x | $34.40 Million | $67.70 Million | $34.40 Million | ▲ +1.6% |
| 1996 | 0.50x | $31.70 Million | $63.40 Million | $31.70 Million | ▼ -26.4% |
| 1995 | 0.68x | $31.30 Million | $46.10 Million | $31.30 Million | ▲ +24.8% |
| 1994 | 0.54x | $27.10 Million | $49.80 Million | $27.10 Million | ▼ -37.5% |
| 1993 | 0.87x | $33.50 Million | $38.50 Million | $33.50 Million | ▲ +32.1% |
| 1992 | 0.66x | $22.40 Million | $34.00 Million | $22.40 Million | ▲ +14.7% |
| 1991 | 0.57x | $25.50 Million | $44.40 Million | $25.50 Million | ▼ -37.7% |
| 1990 | 0.92x | $33.20 Million | $36.00 Million | $33.20 Million | ▲ +15.3% |
| 1989 | 0.80x | $34.30 Million | $42.90 Million | $34.30 Million | — |